ROCHE unveiled its regional headquarters, West China Management Center, in Chengdu yesterday, as it targets China's inland cities to boost sales.
As part of Roche's "West Plus" Initiative, the Switzerland-based company hopes to double sales and employees in the west China region by 2015 compared with this year. It may also expand its research and development activities in the capital of Sichuan Province and step up its collaboration with the Chengdu government.
"Western China currently contributes around 11 percent of Roche's sales in China, and we expect it to grow much more quickly than more developed regions in the country," said Luke Miels, regional head of Roche Pharmaceuticals Asia-Pacific.
In its "China Health Statistics" released earlier this year, the Ministry of Health pointed out that the accessibility of medical service and products in the western region still trails the average level nationwide.
"Roche's key strategy areas include raising patient awareness and increasing the accessibility of Roche's pharmaceutical products," said Penny Wan, general manager of Roche Pharmaceuticals China.
Roche will also boost R&D capacity in Chengdu in addition to the initial clinical trial programs, and research will focus on oncology and virology studies.
Dozens of multinational companies, including IBM, SAP and Siemens, have also set up regional offices or moved R&D operations to Chengdu.